Home/Filings/4/0001209191-22-012953
4//SEC Filing

Rice Steven J. 4

Accession 0001209191-22-012953

CIK 0001706431other

Filed

Feb 23, 7:00 PM ET

Accepted

Feb 24, 9:31 PM ET

Size

7.2 KB

Accession

0001209191-22-012953

Insider Transaction Report

Form 4
Period: 2022-02-22
Rice Steven J.
Chief Administrative Officer
Transactions
  • Award

    Common Stock

    2022-02-22+20,00038,658 total
  • Award

    Stock Option (Right to Buy)

    2022-02-22+40,00040,000 total
    Exercise: $29.48Exp: 2032-02-21Common Stock (40,000 underlying)
Footnotes (2)
  • [F1]Acquisition of restricted stock units pursuant to the Issuer's Equity Incentive Plan.
  • [F2]25% of the shares subject to the stock option vest and become exercisable on February 22, 2023, and the remainder vest in 36 equal monthly installments thereafter.

Issuer

Vir Biotechnology, Inc.

CIK 0001706431

Entity typeother

Related Parties

1
  • filerCIK 0001820108

Filing Metadata

Form type
4
Filed
Feb 23, 7:00 PM ET
Accepted
Feb 24, 9:31 PM ET
Size
7.2 KB